Invited Speakers
Grand Lecture
60 years ERCP - a personal review and perspective

Nib Soehendra
(University Medical Center Hamburg-Eppendorf)
short biography
Professor Nib Soehendra
A Pioneer of Therapeutic Endoscopy and an Inspiring Mentor to Generations of Endoscopists
Professor Nib Soehendra is one of the most distinguished pioneers in the history of gastrointestinal endoscopy. His groundbreaking innovations have played a pivotal role in transforming endoscopy from a primarily diagnostic procedure into an indispensable therapeutic discipline.
Born and raised in Jakarta, Indonesia, Professor Soehendra moved to Hamburg, Germany, in 1961 to pursue his medical education. He graduated from the University of Hamburg in 1968 and subsequently completed his surgical training at Catholic Marien-Hospital and University Hospital Hamburg-Eppendorf under Professor Hans-Wilhelm Schreiber. He began learning endoscopy independently in 1969 and established an endoscopy unit within the Department of Surgery at University Hospital Hamburg-Eppendorf (Universitatsklinikum Hamburg-Eppendorf: UKE) in 1973. In 1989, he was appointed Professor and Director of the Department of Endoscopic Surgery, and in 1999, he became Director of the Department of Interdisciplinary Endoscopy, where he led the training of both gastroenterologists and surgeons.
Professor Soehendra's contributions to therapeutic endoscopy are truly remarkable. In 1980, he pioneered endoscopic biliary stenting, opening a new era in the management of biliary obstruction. He also developed endoscopic cyanoacrylate injection therapy for bleeding gastric varices and introduced numerous innovative endoscopic devices, including the Soehendra biliary dilator, mechanical lithotripter, and polypectomy snare. Many of his innovations have become integral components of modern therapeutic endoscopy and continue to benefit patients worldwide.
Beyond his extraordinary scientific and clinical achievements, Professor Soehendra is an exceptional educator and mentor. Throughout his career, he warmly welcomed numerous young physicians from around the world to Hamburg, generously sharing not only his technical expertise but also his clinical philosophy and passion for innovation. His trainees have subsequently become leaders in gastrointestinal endoscopy across the globe, carrying forward his knowledge, skills, and spirit. He has also made substantial contributions to international endoscopic education through initiatives such as Endo Club Nord.
In recognition of his outstanding contributions, Professor Soehendra received the President's Award from the American Society for Gastrointestinal Endoscopy in 2006 and the prestigious Paracelsus Medal from the German Medical Association in 2016.
Professor Soehendra's legacy extends far beyond the techniques and instruments he developed. He has inspired generations of endoscopists through his creativity, dedication, generosity, and exceptional mentorship. His influence continues to shape the present and future of therapeutic endoscopy.
It is a tremendous honor and privilege to welcome Professor Soehendra to the 113th Annual Congress of the Japan Gastroenterological Endoscopy Society in Toyama. As Congress President and one of his former fellows, I am personally delighted to have this opportunity to introduce my esteemed mentor to our colleagues in Japan and around the world. We eagerly look forward to his special lecture and to learning once again from one of the true legends of therapeutic endoscopy.
Invited Lecture
Invited Lecture1
From the Lumen to the Liver: Endo-Hepatology Comes of Age

Kenneth J Chang
(University of California Irvine Medical Center, USA)
short biography
Kenneth J. Chang, M.D., M.A.S.G.E., A.G.A.F., F.A.C.G., F.J.G.E.S., F.A.F.S joined Hoag as the Executive Medical Director of the Digestive Health Institute. He leads Orange County’s largest digestive health programs and services in expanding the delivery of world-class care. Dr. Chang is a world-renown researcher, inventor, advanced endoscopist and pioneer in the field of interventional endoscopy and endoscopic oncology. He is a board-certified gastroenterologist, who is fellowship trained in gastroenterology and hepatology, and specializes in Interventional Endoscopy, Endoscopic Oncology, Endo-Hepatology, Endo-Bariatrics, and Endoscopic Treatment for GERD and motility disorders.
Dr. Chang attended Brown University in Providence, Rhode Island where he received his combined bachelor’s degree in biology and medical degree. Dr. Chang completed his internship and residency in general internal medicine at Rhode Island Hospital and went on to pursue an academic fellowship in gastroenterology and hepatology at the University of California, Irvine.
Dr. Chang comes to Hoag from the University of California, Irvine, where he practiced for 30 years, building and launching UCI’s Comprehensive Digestive Disease Center and Digestive Health Institute, pioneering numerous breakthrough technologies, publishing over 480 scientific articles, abstracts, book chapters and textbooks, as well as training and mentoring over 50 national and international advanced fellows who are now leaders in their respective regions.
Awarded the Vincent and Anna Kong endowed Chair in GI Endoscopic Oncology in 2013, Dr. Chang’s clinical and research passion has focused on innovating new endoscopic diagnostic and interventional management and cure of Digestive Cancers as well as the pre-cancerous conditions that lead to tumor growth. Pre-cancerous and early stage cancer can now be treated and cured by way of endoscopic ablation and resection techniques, including radio-frequency ablation (RFA), endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD); all of which he has mastered. He considers acid reflux (GERD), obesity, and diabetes as pre-pre-cancerous conditions – hence his efforts to treat these conditions using novel endoscopic approaches, such as Trans-oral incisionless fundoplication (TIF) and endoscopic sleeve gastroplasty (ESG).
As a result, Dr. Chang has developed numerous devices that have touched the lives of patients globally. This would include: 1) Endoscopic Ultrasound-guided Fine Needle Aspiration (FNA) for diagnosing and staging tumors in the pancreas, liver, mediastinum and lymph nodes 2) Endoscopic Radio-frequency Ablation (RFA) for the treatment of Barrett’s Esophagus, which bears the name “Chang Cap” due to his contributions; it is the world’s most popular device for treating and curing Barrett’s 3) Endoscopic Treatment for Gastro-esophageal reflux disease (GERD), being the world’s leading authority and trainer for Trans-oral Incisionless Fundoplication (TIF) and 4) EUS-guided Portal Pressure Gradient (PPG) measurement and Endo-Hepatology – which can assess liver health, quantify liver fibrosis leading to cirrhosis, and determine degree of inflammation caused by fat in the liver (metabolic dysfunction-associated steatohepatitis, or MASH).
Dr. Chang is one of few physicians nationally who has expertise in some of the most advanced endoscopic modalities, such as: Per-oral Endoscopic Myotomy (POEM) for Achalasia, Zenker’s per-oral cricopharyngeal myotomy (Z-POEM), Gastric Per-oral Endoscopic Pyloro-myotomy (G-POEM), Trans-oral Incisionless Fundoplication (TIF), Endoscopic Sleeve Gastroplasty and Revisions (ESG/TORe), Endo-Hepatology including EUS-Liver Biopsy and EUS-portal pressure gradient measurement (EUS-PPG), Endoscopic Submucosal Dissection (ESD).
Throughout his career, Dr. Chang has been recognized with honors and awards as a prominent researcher and pioneer in digestive health. For over 15 consecutive years, he has been named on the Southern California Super Doctors list and recognized as a Physician of Excellence by the Orange County Medical Association. In 2021, he was celebrated as the Orange County Business Journal Innovator of the Year Award Winner.
Dr. Chang is actively involved in organizations on a national and international level including the American College of Physicians, American College of Gastroenterology (Fellow), American Gastroenterological Association (Fellow), American Society of Gastrointestinal Endoscopy (Master; awarded Master Endoscopist in 2022), American Foregut Society (Founding Board Member and Fellow; awarded Distinguished Service Award), Natural Orifice Surgery Consortium for Assessment and Research, Natural Orifice Transluminal Endoscopic Surgery, American Society of Clinical Oncology, Japan Gastroenterological Society, Bockus International Society of Gastroenterology, Christian Medical Society, Orange County Gastroenterology Society and Society of American Gastrointestinal Endoscopic Surgeons.
Finally, Dr. Chang comes to Hoag with a proven leadership track record – where his “servant-leader” posture and his “we before me” approach will be instrumental in further strengthening and expanding the world-class physicians and staff of Hoag’s Digestive Health Institute.
Invited Lecture2
Future of Therapeutic EUS

Kenneth F Binmoeller
(California Pacific Medical Center)
short biography
Kenneth F Binmoeller, MD, FACG, MASGE, FASGE
Chief of Division of Advanced Interventional Gastroenterology and Director of Interventional Endoscopy Services (IES) at California Pacific Medical Center in San Francisco. Dr Binmoeller’s practice of advanced interventional endoscopy has inspired Innovation to improve outcomes and enable new devices and procedures. He is the inventor of the AXIOS lumen-apposing stent and holds over 50 patents for innovative endoscopic technologies. He has authored more than 200 publications and several books. He has trained and mentored endoscopists from all corners of the globe. Fellow of the American College of Gastroenterology (ACG), American Society for Gastrointestinal Endoscopy (ASGE), and Japananese Gastrointestinal Endoscopy Society (JGES). In 2013 the ASGE honored Dr Binmoeller with the Master Endoscopist of the Year Award.
Dr Binmoeller’s training and professional positions have been split between the United States and Europe. He attended medical school at the University of Freiburg in Germany and the University of Bern in Switzerland, followed by internal medicine residency at Baylor College of Medicine in Houston, Texas and gastroenterology fellowship training at Oregon Health Sciences University in Portland, Oregon. Prior University faculty appointments: Nice, France (CHR Cimiez, 1990-1991), Hamburg, Germany (UKE, 1991-1998), San Diego USA (UCSD, 1998-2001).
Invited Lecture3
New trends in POEM

Peter V. Draganov
(University of Florida)
short biography
Dr. Peter Draganov is Professor of Medicine and Director of Advanced Therapeutic Endoscopy at the Division of Gastroenterology, Hepatology and Nutrition at the University of Florida in Gainesville, Florida, USA. He completed medical school in Bulgaria and then trained in Medicine and Gastroenterology including advanced therapeutic endoscopy at the Medical University of South Carolina (MUSC) in Charleston, South Carolina.
Dr. Draganov’s clinical interest is in advanced therapeutic endoscopy including endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), cholangioscopy, endoscopic mucosal resection (EMR), deep small bowel enteroscopy, endoscopic submucosal dissection (ESD), per oral endoscopic myotomy (POEM) and Third Space Endoscopy. Dr. Draganov research interests are in the areas of outcomes research, new technology evaluation, and training in advanced endoscopic procedures.
Invited Lecture4
Endoluminal Robotics - Current and Future Development

Philip WY Chiu
(Chinese University of Hong Kong)
short biography
Professor Philip Wai Yan, CHIU, JP
MBChB(CUHK), MD(CUHK), FRCSEd(Gen), FCSHK, FHKAM (Surgery)
Dean, Faculty of Medicine, The Chinese University of Hong Kong
Professor Philip Chiu is the Dean of the Faculty of Medicine, Shun Hing Education and Charity Fund Professor of Robotic Surgery, Director of Multi-Scale Medical Robotics Center, and Director of Endoscopy Center, Institute of Digestive Disease of The Chinese University of Hong Kong. He is also a Steering Committee member of Health and Medical Innovation Development of the Health Bureau of the HKSAR Government, and President-Elect of the World Endoscopy Organization (WEO).
Professor Chiu graduated from the Faculty of Medicine, The Chinese University of Hong Kong in 1994 with two scholarships. He became a fellow of the Royal College of Surgeons of Edinburgh (General Surgery), Hong Kong Academy of Medicine in 2001, and received his Doctor of Medicine from CUHK in 2009.
Professor Chiu is a pioneer in minimally invasive procedures, having performed Hong Kong’s first endoscopic submucosal dissection (ESD) for the treatment of early gastrointestinal cancers in 2004, as well as the world’s first robotic gastric ESD and colorectal ESD in 2011 and 2020 respectively. His research interests include esophageal cancer management, minimally invasive and robotic esophagectomy, novel endoscopic technologies for diagnosis of early GI cancers, endoscopic surgery as well as robotics for endoluminal surgery. Professor Chiu has published nearly 400 peer-reviewed manuscripts with an H-index of 74. Among these, his seminal world’s first robotic colorectal ESD clinical study earned Endoscopy's Most Innovative Paper Award (2024). Other accolades include the State Scientific Technology and Progress Award from the People’s Republic of China (2007), 2nd class award in Technological Advancement, Ministry of Education of the People’s Republic of China (2011), Spirit of Hong Kong Award on Innovation (2020), two Gold Medals with Congratulations of Jury at the International Exhibitions of Inventions of Geneva (2019, 2023), Honorary Member of the European Association of Endoscopic Surgery (2023), Foreign Member of the Academia Europaea (2025) and Fellow of International Academy of Artificial Intelligence Sciences (2026).
Invited Lecture5
Beyond Adenoma Detection Rate: What Does It Take to Prevent Post-Colonoscopy Colorectal Cancer?

Han-Mo Chiu
(National Taiwan University Hospital)
short biography
Prof. Chiu’s career is defined by his extensive work in public health as the Principal Investigator of the Taiwan Colorectal Cancer Screening Program. Under his leadership, Taiwan has developed one of the most successful FIT-based screening programs globally, providing definitive evidence for long-term mortality reduction and setting a benchmark for organized cancer control. A core pillar of his work in this program has been the standardization and elevation of colonoscopy quality. His research has established critical quality indicators, such as the adenoma detection rate and cecal intubation rate, in FIT screening program and has explored how fecal hemoglobin concentrations can predict interval cancers resulting from suboptimal colonoscopy quality. These efforts have fundamentally improved the safety and efficacy of the screening continuum in Taiwan and beyond.
His international influence is centered on his leadership within the World Endoscopy Organization (WEO), where he serves as the Regional Chair for the Colorectal Cancer Screening Committee, and the Asia-Pacific Working Group on CRC. Prof. Chiu has co-authored multiple foundational consensus recommendations that have standardized CRC screening and post-polypectomy surveillance worldwide. He has been recognized with the Research Excellence Award from the National Council of Science and Technology of Taiwan (2023), numerous Abstract Awards from Digestive Disease Week (Plenary talk: 2012, Distinguished abstract 2015, 2016, 2021, Best of DDW: 2025). He was also awarded Marshall-Warren Lectureship, the most prestigious award in the field in luminal GI in the Asia-Pacific, in 2026.
Prof. Chiu holds a PhD from the Institute of Preventive Medicine, National Taiwan University. His recent research focuses on metabolic drivers of early-onset CRC, AI-assisted colonoscopy, and the environmental sustainability of endoscopic practices. His professional affiliations also include being a fellow of the Japanese Gastroenterological Endoscopy Society and a visiting professorship at Gunma University, Japan.
Invited Lecture6
Evolving Treatment Targets in IBD

Marc Ferrant
(Leuven University)
short biography
Prof. Dr. Marc Ferrante is full professor at KU Leuven (Leuven, Belgium) and staff member of the Department of Gastroenterology and Hepatology at the University Hospitals Leuven since 2012. He is a lecturer for the students of Biomedical Sciences and Medicine.
Marc Ferrante introduced the ex vivo intestinal organoid technique at KU Leuven. He performed research on the influence of microbiota on intestinal stem cell behaviour and differentiation in patients with IBD. Besides, he also started a research line on patient reported outcomes, quality indicators and eligibility criteria for clinical trials.
Marc Ferrante published more than 380 papers in high ranked gastroenterology journals (H index: 80). He was awarded as Rising Star in Gastroenterology at the European Congress of Gastroenterology in 2014.
Marc Ferrante holds a basic-clinical research position at the Flemish Foundation for Scientific Research (FWO Vlaanderen). He is Secretary of the Belgian IBD Research and Development (BIRD) group. He has been Chair of both the Young, Clinical and Scientific Committee of the European Crohn’s and Colitis Organisation (ECCO).